US Broker Ratings

Oric Pharmaceuticals, Inc. (ORIC) Stock Report: Analyzing a 36.98% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a prominent player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 36.98%, according to analyst..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring an 89% Potential Upside

Organogenesis Holdings Inc. (NASDAQ: ORGO) is a notable player in the healthcare sector, particularly focusing on regenerative medicine. With a market capitalization of $536.61 million, the..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: 13.89% Potential Upside and Promising Clinical Trials

Maze Therapeutics, Inc. (NASDAQ: MAZE) is making headlines with its intriguing position in the biotechnology sector. With a market capitalization of $1.6 billion, this clinical-stage biopharmaceutical..

AngioDynamics, Inc. (ANGO) Stock Analysis: Is a 52.39% Upside on the Horizon?

For individual investors seeking promising opportunities in the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents a compelling case. With a potential upside of 52.39%, as suggested..

Humacyte, Inc. (HUMA) Stock Analysis: A Bold 411% Upside Potential in Biotech Innovation

In the dynamic world of biotechnology, Humacyte, Inc. (NASDAQ: HUMA) stands out as a company to watch, promising significant potential upside for investors. Currently trading at..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A 47.15% Potential Upside in Healthcare Diagnostics

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare diagnostics sector with its innovative molecular diagnostics solutions. Headquartered in Friendswood, Texas, Castle Biosciences provides test..

Opthea Limited (OPT) Stock Analysis: Navigating a -70.67% Potential Downside in Biotech

For investors keen on the biotechnology sector, Opthea Limited (NASDAQ: OPT), a clinical-stage biopharmaceutical company headquartered in Melbourne, Australia, may present a captivating yet complex opportunity...

Tourmaline Bio, Inc. (TRML) Stock Analysis: Navigating Biotech Volatility with a 0.04% Potential Upside

For investors keeping a close eye on the biotechnology sector, Tourmaline Bio, Inc. (NASDAQ: TRML) represents a compelling opportunity with its current positioning in the healthcare..

PureTech Health plc (PRTC) Stock Report: Unveiling a 170% Upside Opportunity in Biotech

PureTech Health plc (NASDAQ: PRTC), a biotechnology company focused on innovative therapies, has piqued investor interest with a notable potential upside of 170.59%, according to analyst..

Tilray Brands, Inc. (TLRY) Stock Analysis: Can This Cannabis Giant Overcome a Challenging Market?

Tilray Brands, Inc. (NASDAQ: TLRY), a prominent player in the global cannabis industry, presents a mixed bag of opportunities and challenges for investors. With a current..

Rapport Therapeutics, Inc. (RAPP)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: 502 Bad Gateway 502 Bad Gateway clou (truncated…)

..

Abivax SA (ABVX) Stock Analysis: Striking Growth Potential with an Average Target Upside of 12.43%

Abivax SA (ABVX), a recognized player in the biotechnology sector, is capturing the attention of investors with its impressive market presence and potential growth trajectory. This..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: A Compelling 181% Upside Potential in Retinal Therapeutics

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is garnering significant attention in the biotechnology sector, with its eye-catching potential upside of 181.87%. The company, headquartered in Watertown, Massachusetts,..

Verastem, Inc. (VSTM) Stock Analysis: Exploring a Potential 67.93% Upside in the Biotech Sector

Verastem, Inc. (VSTM), a biopharmaceutical company based in Needham, Massachusetts, operates within the dynamic biotechnology industry, focusing on innovative cancer treatments. With a market capitalization of..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A 186% Revenue Growth Powering Biotech Ambitions

Stoke Therapeutics, Inc. (NASDAQ: STOK) stands as a promising player in the biotechnology sector, drawing the attention of investors with its innovative approach to treating severe..

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a 147.62% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS) is capturing investor attention with its bold strides in the healthcare sector, particularly in the niche of mental health treatments. The..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 45.77% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices industry with a market capitalization of $610.98 million, has been capturing the attention of..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Landscape with a $710 Million Market Cap

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a player in the burgeoning biotechnology sector, presents a fascinating case for investors with its innovative approach to cell programming..

Inventiva S.A. (IVA) Stock Analysis: Exploring a Promising 282% Potential Upside in Biotechnology

Investors with a keen eye on the healthcare sector might find Inventiva S.A. (IVA), a French biotechnology firm, an intriguing opportunity given its potential 282.53% upside...

AxoGen, Inc. (AXGN) Stock Analysis: Strong Buy Ratings and 20.7% Potential Upside Propel Investor Interest

AxoGen, Inc. (NASDAQ: AXGN), a pioneer in the healthcare sector focused on medical devices for peripheral nerve regeneration, is capturing investor attention with its robust growth..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds